Cellosaurus logo
expasy logo

Cellosaurus UKAi007-A (CVCL_A5MZ)

[Text version]
Cell line name UKAi007-A
Synonyms P13_wt5; Patient 2 control 1
Accession CVCL_A5MZ
Resource Identification Initiative To cite this cell line use: UKAi007-A (RRID:CVCL_A5MZ)
Comments From: Universitatsklinikum Aachen; Aachen; Germany.
Characteristics: Established from a patient that has a KIT p.Asp816Val mutation, but this cell line does not contain this mutation.
Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
Sequence variations
  • Mutation; HGNC; 76; ABL1; Simple; p.Gly725Ser (c.2173G>A) (p.Gly706Ser, c.2116G>A); ClinVar=VCV000133445; Zygosity=Heterozygous (PubMed=33512435).
  • Mutation; HGNC; 5382; IDH1; Simple; p.Val178Ile (c.532G>A); ClinVar=VCV000134520; Zygosity=Heterozygous (PubMed=33512435).
  • Mutation; HGNC; 8803; PDGFRA; Simple; p.Ser478Pro (c.1432T>C); ClinVar=VCV000041794; Zygosity=Heterozygous (PubMed=33512435).
  • Mutation; HGNC; 10471; RUNX1; Simple; p.Val101Alafs*31 (c.302_318del); Zygosity=Heterozygous (PubMed=33512435).
  • Mutation; HGNC; 10783; SRSF2; Simple; p.Pro95_Arg102del (c.284_307del); dbSNP=rs766200080; Zygosity=Heterozygous (PubMed=33512435).
  • Mutation; HGNC; 25941; TET2; Simple; p.Ser1292Arg (c.3876C>G); Zygosity=Heterozygous (PubMed=33512435).
  • Mutation; HGNC; 25941; TET2; Simple; p.Arg1465Ter (c.4393C>T); ClinVar=VCV001899776; Zygosity=Heterozygous (PubMed=33512435).
  • Mutation; HGNC; 11998; TP53; Simple; p.Pro72Arg (c.215C>G); ClinVar=VCV000012351; Zygosity=Homozygous (PubMed=33512435).
Disease Systemic mastocytosis (NCIt: C9235)
Systemic mastocytosis (ORDO: Orphanet_2467)
Species of origin Homo sapiens (Human) (NCBI Taxonomy: 9606)
Originate from same individual CVCL_A5NA ! UKAi007-B
Sex of cell Male
Age at sampling 90Y
Category Induced pluripotent stem cell
Publications

PubMed=33512435; DOI=10.1182/blood.2019004509
Szymanski de Toledo M.A., Gatz M., Sontag S., Gleixner K.V., Eisenwort G., Feldberg K., Hamouda A.E.I., Kluge F., Guareschi R., Rossetti G., Sechi A.S., Dufva O.M.J., Mustjoki S.M., Maurer A., Schuler H.M., Goetzke R., Braunschweig T., Kaiser A., Panse J., Jawhar M., Reiter A., Hilberg F., Ettmayer P., Wagner W., Koschmieder S., Brummendorf T.H., Valent P., Chatain N., Zenke M.
Nintedanib targets KIT D816V neoplastic cells derived from induced pluripotent stem cells of systemic mastocytosis.
Blood 137:2070-2084(2021)

Cross-references
Cell line databases/resources hPSCreg; UKAi007-A
Biological sample resources BioSamples; SAMEA8268471
Encyclopedic resources Wikidata; Q107117229
Entry history
Entry creation20-May-2021
Last entry update29-Jun-2023
Version number4